Thelansis’s "Geographic Atrophy (GA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Geographic Atrophy treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Geographic atrophy (GA) marks the advanced stage of the dry variant of age-related macular degeneration (AMD). Some individuals with AMD may develop GA, characterized by the deterioration and death of cells in specific regions of the retina. The border of GA signifies the endpoint of continuous retinal pigment epithelium (RPE), with an internal absence of RPE cells, although a few are scattered within the GA area. Initial manifestations of AMD include drusen and irregularities in the retinal pigment epithelium (RPE). This early stage, known as age-related maculopathy (ARM), may progress to GA or exudative AMD. Around 11% of atrophic AMD patients transition to the exudative form after four years. Choroidal neovascularization (CNV) in some eyes can also lead to GA.
G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)
*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.
1. Key Findings and Analyst Commentary
2. Disease Context
3. Epidemiology
4. Market Size and Forecast
5. Competitive Landscape
6. Unmet Need and TPP Analysis
7. Regulatory and Reimbursement Environments (by country and payer insights)
8. Appendix (e.g., bibliography, methodology)
No snapshots available.
That depends on the file type you choose: the Excel epidemiology model, the Excel market forecast model with dashboard, and the full analyst report in PowerPoint with a PDF version.
Within 48 to 72 hours of purchase.
Yes. Choose EU5, G7 or G8, or pick individual markets in the panel.
Yes. Request a free sample to preview the scope and sample pages.
Yes. The forecast model is customizable, and our analysts can tailor the scope to your questions.
Yes. Inquire for bundle discounted pricing and we will send you exclusive pricing for the reports you need.
Choose the file type you want to purchase or request.
No file type found.
Select markets to include.
No markets match your search.
Not sure which report fits your question? Our team will point you to the right one.
Tell us what you are looking for and we will tailor the research to your indication, markets and questions.
Prefer to talk it through? Email clientsupport@thelansis.com
You asked for for covering . We will reply to .
Fill in your details and our expert consultants will get in touch with you.
Get a sneak peek at the latest Geographic Atrophy (GA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035 report
Our team will get in touch with you shortly about the Geographic Atrophy (GA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035 report.